首页> 外文期刊>Pharmaceutical Chemistry Journal >STUDY OF DOLUTEGRAVIR DEGRADATION AND SPECTROSCOPIC IDENTIFICATION OF PRODUCTS BY LCMS, H-1 AND C-13 NMR TECHNIQUES
【24h】

STUDY OF DOLUTEGRAVIR DEGRADATION AND SPECTROSCOPIC IDENTIFICATION OF PRODUCTS BY LCMS, H-1 AND C-13 NMR TECHNIQUES

机译:LCMS,H-1和C-13 NMR技术DoluteGravir降解和光谱鉴定的研究

获取原文
获取原文并翻译 | 示例
       

摘要

Stability study for dolutegravir bulk drug was performed and the degradation products formed were identified by chromatography (HPLC, LCMS) and spectroscopy (ESI-MS, FTIR, H-1 and C-13 NMR) techniques. Degradation of the drug in acidic and peroxide environment yielded one common major degradant f ((2,4-difluorophenyl)methanamine) with a mass peak at m/z = 182.44. In addition to this, five more minor degradation products (a, b, c, d and e) were formed. The structure interpretation showed that the drug degraded to its synthetic precursor and no extra structures were formed. Hence, it was suggested that drug dolutegravir should be kept away from acidic and oxygen rich conditions.
机译:进行稳定性研究DoluteGravir散装药物,并通过色谱(HPLC,LCMS)和光谱(ESI-MS,FTIR,H-1和C-13 NMR)技术鉴定形成的降解产物。 药物在酸性和过氧化物环境中降解药物,得到一种常见的主要降解F((2,4-二氟苯基)甲烷胺,M / Z = 182.44的质量峰。 除此之外,还形成了五种更小的降解产物(A,B,C,D和E)。 结构解释表明,该药物降解到其合成前体,没有形成额外的结构。 因此,有人提出,药物DoluteGravir应远离酸性和富含氧气的条件。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号